FDA Inspection
Boehringer Ingelheim Biopharmaceuticals (China) Ltd.FDA Inspection 1330776 - Boehringer Ingelheim Biopharmaceuticals (China) Ltd. - July 24, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Boehringer Ingelheim Biopharmaceuticals (China) Ltd., with an inspection on July 24, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- July 24, 2026
- Product Type
- Human Drugs
Open in Dashboard
ID · 0ce26aa4-613f-4fcb-be37-03eb4ca234cd